1-5 of 5
Athos Gianella-Borradori
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Study of Elacytarabine/Idarubicin As Second Course Remission-Induction in Patients with Acute Myeloid Leukemia Who Failed Cytarabine/Anthracycline

David A. Rizzieri, MD, Norbert Vey, MD, PhD, Xavier Thomas, MD, Françoise Huguet, Richard F Schlenk, MD, Jürgen Krauter, MD, Ph.D., Thomas Kindler, MD, Bjorn Gjertsen, MD, PhD, Igor W. Blau, Malin Johansen, Trygve Bergeland, Athos Gianella-Borradori, Tove Flem Jacobsen, Jianyu Rao, MD, Utz Krug
Journal: Blood
Blood (2012) 120 (21): 46.
https://doi.org/10.1182/blood.V120.21.46.46
Published: 2012
Journal Articles

Preliminary Clinical, Pharmacokinetic (PK) and Pharmacodynamic (PD) Results of the Safety Run In Part of a Phase II Trial of the Orally Available MEK-Inhibitor MSC1936369 In Patients with Advanced Hematological Malignancies

Farhad Ravandi, MD, Arnaud Pigneux, MD, PhD, Douglas Smith, MD, Hervé Dombret, Xavier Thomas, MD, PhD, Hagop M. Kantarjian, MD, Jorge E. Cortes, Daniel J DeAngelo, MD, PhD, Keith W Pratz, MD, Ekaterine Asatiani, MD, Athos Gianella-Borradori, MD, Blandine Longerey, Jean-Luc Harousseau
Journal: Blood
Blood (2010) 116 (21): 3296.
https://doi.org/10.1182/blood.V116.21.3296.3296
Published: 2010
Journal Articles

Final Results of a Phase Ib Trial of Atacicept to Neutralize APRIL and BLyS in Patients with Refractory or Relapsed Chronic Lymphocytic Leukemia (CLL).

David M Kofler, MD, Barbara B Gawlik, MD, Thomas Elter, MD, Athos Gianella-Borradori, MD, Clemens M Wendtner, MD, Michael Hallek, MD
Journal: Blood
Blood (2009) 114 (22): 2373.
https://doi.org/10.1182/blood.V114.22.2373.2373
Published: 2009
Journal Articles

Phase I, Dose-Escalation Study of 2 Dosing Regimens of AS703569, An Inhibitor of Aurora and Other Kinases, Administered Orally in Patients with Advanced Hematological Malignancies

Anne Sonet, Carlos Graux, Johan Maertens, Christine-Maria Hartog, Justus Duyster, Katharina Götze, Jochen Greiner, Marie-Luise Hütter, Alois Gratwohl, Dominik Heim, Dagmar Hess, Yves Chalandon, Athos Gianella-Borradori, Narmyn Rejeb, Oliver Ottmann
Journal: Blood
Blood (2008) 112 (11): 2963.
https://doi.org/10.1182/blood.V112.11.2963.2963
Published: 2008
Journal Articles

A novel CDK inhibitor, CYC202 (R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival

Azra J. Alvi, Belinda Austen, Victoria J. Weston, Christopher Fegan, David MacCallum, Athos Gianella-Borradori, David P. Lane, Mike Hubank, Judith E. Powell, Wenbin Wei, A. Malcolm R. Taylor, Paul A. H. Moss, Tatjana Stankovic
Journal: Blood
Blood (2005) 105 (11): 4484–4491.
https://doi.org/10.1182/blood-2004-07-2713
Published: 2005